Viewing StudyNCT06206096



Ignite Creation Date: 2024-05-06 @ 7:57 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06206096
Status: RECRUITING
Last Update Posted: 2024-04-30
First Post: 2024-01-04

Brief Title: PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC
Sponsor:
Organization: Chinese PLA General Hospital